The state of bioinformatics in the fight against AMR
In 2021, technology platforms and solutions that simplify and facilitate detection of drug-resistant infections will continue to evolve and provide value in the fight against AMR. With more and more healthcare systems adopting platforms that deliver treatment insights to enable smarter use of antibiotics, we can expect to see an uptick in cloud-based solutions that encourage collaboration between healthcare facilities and providers. Additionally, as the world continues to grapple with the Covid-19 pandemic, data-sharing platforms capable of delivering broader insights on infectious disease outbreaks will become valuable solutions for epidemiologists and frontline workers alike.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.